For research use only
| Cat No. | ABC-X0338C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Lymphocytes |
| Species | Human |
| Host Cell | BAF3 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Human CD66e (CEA) stably expressed in BAF3 cells, commonly used in tumor immunology, cell adhesion, and targeted therapy development in carcinomas.
Xpress™ Human CD66e Overexpression Cell Line is a genetically engineered model derived from selected murine pro-B (BAF3) parental cell line based on customers’ requirement. CD66e BAF3 overexpression cell line is generated by stable integration of exogenous human CD66e into BAF3 host cells using our optimized transduction of lentiviral vectors. Overexpression clone is validated at gene level by qRT-PCR.
Target
The CD66e gene (also known as CEACAM5) encodes a cell adhesion molecule overexpressed in gastrointestinal, pancreatic, and lung cancers. It is involved in cell signaling, immune response modulation, and tumor metastasis. CD66e is a key biomarker and target in oncology. AcceGen offers generation of stable overexpression cell lines targeting any gene of your interest. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0338C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Lymphocytes |
| Growth Mode | Suspension |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO2 |
| Source Organ | Lymphatic |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | BAF3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The CD66e BAF3 Overexpression Cell Line serves as a powerful tool for studying tumor cell interactions, immune escape, and CEACAM-targeted therapy development in cancer.